Step 1

Draft

Step 2

Unite with Fellow Investors

Step 3

Choose the Best Attorney

Step 4

Provide Documents

Step 5

Follow Case Progress

Step 6

Get Payout

QSI.US

id: 1824

HighCape Capital ($CAPA) $7.6M Stockholder Settlement

Eligible claimants can submit their claims for compensation.

$7,600,000

Cash Settlement

Delaware court of Chancery

Court

2024-0524-LWW

Case number

05/09/2021

Class period Start

06/09/2021

Class period End

05/06/2026

Claim deadline

HighCape Capital ($CAPA) agreed to a $7.6 million settlement to resolve claims it misled investors about Quantum-Si’s readiness for commercial launch and business outlook in connection with their SPAC merger.

Outline

In June 2021, HighCape Capital, a SPAC, merged with Quantum-Si, a biotech firm focused on single-molecule protein sequencing. However, it was later accused of providing misleading information about Quantum-Si’s product development, commercialization prospects, and financial projections leading up to and after the merger. Following this, the stock dropped by 70%, and investors filed a lawsuit.

Timeline
On June 10, 2021: HighCape completed its merger with Quantum-Si, and the combined company began trading as $QSI.
Between 2022 and 2023: Quantum-Si missed growth and commercialization targets, and $QSI shares declined over 70%, leading to significant investor losses.
In May 2024: Shareholders filed a class action citing material omissions and misstatements.
In January, 2026: The court set May 6, 2026, as the deadline to submit claims for the settlement.
Background

In June 2021, Quantum-Si Incorporated, a life sciences firm specializing in protein sequencing technology, entered the public markets following a merger with HighCape Capital Acquisition Corp.

At the time of the merger, the company was positioned as a pioneer in commercializing innovative technology for the healthcare sector. The leadership presented optimistic projections regarding commercialization timelines and revenue growth to build momentum.

And, the deal was initially met with significant investor enthusiasm.
However, the post-merger reality shifted as the company struggled to hit its commercialization and revenue milestones.

Quantum-Si faced operational delays and missed key product rollout timelines that had been central to its early projections.

As these challenges became clear to the market, investor confidence evaporated, and $QSI had plummeted over 70% from its post-merger highs.

In response to the decline, investors filed a class action lawsuit, claming that the HighCape Defendants impaired stockholders' redemption rights and provided misleading information in the Proxy statement used to approve the merger.

What Can Investors Expect Now?

HighCape Capital ($CAPA) agreed to a $7.6 million settlement to resolve claims it misled investors about Quantum-Si’s readiness for commercial launch and business outlook in connection with their SPAC merger.

If you were damaged due to this situation, you can file for a payout and get your share of the settlement. You can check if you are eligible and other details in the FAQ section below.

Case Type

US Securities Class Action

Case Status

Accepting Claims

Alleged Offence

Mismanagement,

Misleading Statements,

Failure to Disclose,

Breach of Fiduciary duty

Suspected Party

Directors

Security Type

Stocks

Trade Direction

Long

Filing date

05/05/2024

Plaintiffs

MICHAEL FARZAD

Attorneys

Bernstein Litowitz Berger & Grossmann LLP

Defendants

KEVIN RAKIN, MATT ZUGA, DAVID COLPMAN, ROBERT TAUB, ANTONY LOEBEL, JONATHAN M. ROTHBERG

Administrator

JND Legal Administration

Settlement agreement date

2025-12-23

Court hearing date

03/26/2026

Objection deadline

03/12/2026

Attorney fee

$1,520,000

Trades matching type

FIFO

Frequently Asked Questions

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.